Catalent: Q4 currency glitch but CDMO to gain from consolidation trend
Ongoing consolidation in the CDMO industry is beneficial for Catalent, the firm says as it reports a fourth quarter marred by weak currencies.
Archives for September 2, 2015
Japan hits Pfizer with business improvement order after ADR reporting failures
Pfizer failed to report hundreds of serious adverse drug reactions (ADRs) in the required timeframes according to Japan’s Ministry of Health, Labor and Welfare (MHLW) which has issued the US firm with a business improvement order.
CeQur's $100m financing to scale-up insulin delivery patch-pump production
GLP-1 drugs and oral formulations will not diminish demand for insulin patch-pumps says CeQur, which has raised $100m (€89m) to support production of its PaQ delivery device.
Update - Wholesale cost of Zarxio will be 15% less than Amgen's Neupogen
Biosimilars land in the US as Sandoz launches Zarxio
Sandoz has launched Zarxio, the first biosimilar in the US, despite a last ditch effort to block the copycat version of Neupogen by Amgen.
Sanofi seeks to expand UK inhalables site with an eye on CMO business
Sanofi wants to expand its inhalable drug production site in Cheshire, UK to increase capacity for both its own brand drug production operations and its contract manufacturing business.